| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |